摘要
目的:评估血浆凝血酶原活性在重症肝病早期诊断中的应用价值。方法:采用巨齿蛇毒发色底物法检测了100例献血员和115例重症肝病患者的FⅡ:CA,并同步检测预示重症肝病的其他指标。结果:FⅡ:CA正常参考范围(85.0-131.0)%,重症肝病患者的FⅡ:CA与正常对照及预示重症肝病的其他指标比较均具有显著性差异。
Objective:To evaluate application of plasma (actor Ⅱ coagulant activity (FⅡ:CA) in the early diagnosis of serious hepatitis (SH) disease.Methods:Echis carinatus venon chromogenic substrate assay (ECVCSA) was in the detection of FⅡ:CA in the plasma of 100 helth subjects and in 115 patients with SH and other terms of SH. Result:nonnal FⅡ:CA referene levels were (85.0~131.0%).FⅡ:CA of SH was more significantly higher than levels of normal group and other terms levels of SH. Conclusion:The detection of FⅡ:CA may be one of the terms of SH in the early diagnosis.
关键词
凝血酶原活性
重症肝病
ECVCSA
plasma factor Ⅱ coagulant activity
Echis carinatus venon chromogenic substrate assay
serious hepatitis disease.